Gerald Newmin - Multicell Techs Chairman
Chairman
Mr. W. Gerald Newmin is Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary of MultiCell Technologies Inc. Mr. Newmin joined the Company as a director in June 1995. Mr. Newmin served as Chief Executive Officer of MultiCell from June 1995 to May 2006, and was appointed to serve again as Chief Executive Officer on December 21, 2007. Mr. Newmin is Chairman, Chief Executive Officer, Secretary and a director of Xenogenics, a partiallyowned subsidiary of MultiCell and Chief Executive Officer, Secretary and a director of MCTI, a partiallyowned subsidiary of MultiCell. He has managed New York Stock Exchange and American Stock Exchange Fortune 500 companies. He was President of HealthAmerica Corporationrationration, then the nations largest publiclyheld HMO management company. He was Chief Executive Officer and President of The International Silver Company, a diversified multinational manufacturing company that he restructured. He was Chief Operating Officer of numerous Whittaker Corporation operating units, including Production Steel Company, Whittaker Textiles, Bertram Yacht, Trojan Yacht, Columbia Yacht, Narmco Materials and Anson Automotive. He was instrumental in Whittakers entry into the U.S. and international health care markets. He was Western Regional Vice President of American Medicorp, Inc, where he managed 23 acute care hospitals in the Western United States. He retired as Chairman and Chief Executive Officer of SYS Technologies, Inc., a highgrowth defense technology company in 2003 since 2007.
| Age | 86 |
| Tenure | 17 years |
| Phone | 401-762-0045 |
| Web | www.multicelltech.com |
Multicell Techs Management Efficiency
The company has return on total asset (ROA) of (1.3637) % which means that it has lost $1.3637 on every $100 spent on assets. This is way below average. Multicell Techs' management efficiency ratios could be used to measure how well Multicell Techs manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 1 records | CHAIRMAN Age | ||
| Richard Ferrari | Tenon Medical | 70 | |
Management Performance
| Return On Asset | -1.36 |
Multicell Techs Leadership Team
Elected by the shareholders, the Multicell Techs' board of directors comprises two types of representatives: Multicell Techs inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Multicell. The board's role is to monitor Multicell Techs' management team and ensure that shareholders' interests are well served. Multicell Techs' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Multicell Techs' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gerald Newmin, Chairman, CEO and President CFO, Treasurer and Secretary | ||
| Barbara Corbett, Manager of Investor Relations |
Multicell Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Multicell Techs a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -1.36 | |||
| Profit Margin | (0.31) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | 1.22 M | |||
| Shares Outstanding | 5 B | |||
| Shares Owned By Insiders | 9.90 % | |||
| Price To Sales | 0.01 X | |||
| Revenue | 49.32 K | |||
| Gross Profit | 49.32 K | |||
| Net Income | (380.07 K) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Multicell Pink Sheet Analysis
When running Multicell Techs' price analysis, check to measure Multicell Techs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Multicell Techs is operating at the current time. Most of Multicell Techs' value examination focuses on studying past and present price action to predict the probability of Multicell Techs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Multicell Techs' price. Additionally, you may evaluate how the addition of Multicell Techs to your portfolios can decrease your overall portfolio volatility.